BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9264548)

  • 1. Denatured proteins as cofactors for plasminogen activation.
    Machovich R; Owen WG
    Arch Biochem Biophys; 1997 Aug; 344(2):343-9. PubMed ID: 9264548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis of the cofactor function of denatured albumin in plasminogen activation by tissue-type plasminogen activator.
    Galántai R; Módos K; Fidy J; Kolev K; Machovich R
    Biochem Biophys Res Commun; 2006 Mar; 341(3):736-41. PubMed ID: 16438933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Actin stimulates plasmin generation by tissue and urokinase-type plasminogen activators.
    Lind SE; Smith CJ
    Arch Biochem Biophys; 1993 Nov; 307(1):138-45. PubMed ID: 8239651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myosin as cofactor and substrate in fibrinolysis.
    Machovich R; Ajtai K; Kolev K; Owen WG
    FEBS Lett; 1997 Apr; 407(1):93-6. PubMed ID: 9141488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of native and denatured whey proteins on plasminogen activator activity.
    Rippel KM; Nielsen SS; Hayes KD
    J Dairy Sci; 2004 Aug; 87(8):2344-50. PubMed ID: 15328255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Facilitation of plasminogen activation by a plasmin substrate containing a lysyl residue.
    Machovich R; Owen WG
    Thromb Haemost; 1993 Nov; 70(5):864-6. PubMed ID: 8128447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma fibronectin enhances fibrinolytic system in vitro.
    Gilboa N; Kaplan JE
    Thromb Haemost; 1985 Oct; 54(3):639-44. PubMed ID: 2935966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Pseudomonas fluorescens M3/6 bacterial protease on plasmin system and plasminogen activation.
    Frohbieter KA; Ismail B; Nielsen SS; Hayes KD
    J Dairy Sci; 2005 Oct; 88(10):3392-401. PubMed ID: 16162512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasminogen binding properties of macrophage inflammatory protein (MIP)-2alpha.
    Arza B; Félez J; Fábregas P; Laroche Y; Collen D; Lijnen HR
    Thromb Haemost; 2000 Jul; 84(1):71-7. PubMed ID: 10928473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of cell surface mediated plasminogen activation by a monoclonal antibody against alpha-Enolase.
    López-Alemany R; Longstaff C; Hawley S; Mirshahi M; Fábregas P; Jardí M; Merton E; Miles LA; Félez J
    Am J Hematol; 2003 Apr; 72(4):234-42. PubMed ID: 12666133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasminogen activator inhibitor type 2 inhibits cell surface associated tissue plasminogen activator in vitro: potential receptor interactions.
    Lobov S; Croucher DR; Saunders DN; Ranson M
    Thromb Haemost; 2008 Aug; 100(2):319-29. PubMed ID: 18690354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stachybotrydial selectively enhances fibrin binding and activation of Glu-plasminogen.
    Sasaoka M; Wada Y; Hasumi K
    J Antibiot (Tokyo); 2007 Nov; 60(11):674-81. PubMed ID: 18057696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor-mediated regulation of plasminogen activator function: plasminogen activation by two directly membrane-anchored forms of urokinase.
    Vines DJ; Lee SW; Dichek DA; Ellis V
    J Pept Sci; 2000 Sep; 6(9):432-9. PubMed ID: 11016879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A spectrophotometric assay for the determination of the catalytic efficiency of plasminogen activators using a slowly hydrolyzed plasmin substrate.
    Castro MJ; Kingston IB; Anderson S
    Anal Biochem; 1995 Apr; 226(2):225-31. PubMed ID: 7793622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of synthetic B knobs to fibrinogen changes the character of fibrin and inhibits its ability to activate tissue plasminogen activator and its destruction by plasmin.
    Doolittle RF; Pandi L
    Biochemistry; 2006 Feb; 45(8):2657-67. PubMed ID: 16489759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmin cleavage of the amyloid beta-protein: alteration of secondary structure and stimulation of tissue plasminogen activator activity.
    Van Nostrand WE; Porter M
    Biochemistry; 1999 Aug; 38(35):11570-6. PubMed ID: 10471309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cowpox virus serpin SPI-3 complexes with and inhibits urokinase-type and tissue-type plasminogen activators and plasmin.
    Turner PC; Baquero MT; Yuan S; Thoennes SR; Moyer RW
    Virology; 2000 Jul; 272(2):267-80. PubMed ID: 10873770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of cellular binding sites and interactive regions within reactants required for enhancement of plasminogen activation by tPA on the surface of leukocytic cells.
    Félez J; Miles LA; Fábregas P; Jardí M; Plow EF; Lijnen RH
    Thromb Haemost; 1996 Oct; 76(4):577-84. PubMed ID: 8902999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of substituted laminin A chain-derived peptides on the conformation and activation kinetics of plasminogen.
    Stack MS; Pizzo SV
    Arch Biochem Biophys; 1994 Feb; 309(1):117-22. PubMed ID: 8117101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of heparin with plasminogen activators and plasminogen: effects on the activation of plasminogen.
    Andrade-Gordon P; Strickland S
    Biochemistry; 1986 Jul; 25(14):4033-40. PubMed ID: 2943315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.